Radiotherapy concurrent with trastuzumab is well tolerated in the adjuvant treatment of women with HER2-positive breast cancer: cardiac safety data from the NCCTG N9831 study (original) (raw)

European Journal of Cancer Supplements, 2006

Michele Halyard hasn't uploaded this paper.

Let Michele know you want this paper to be uploaded.

Ask for this paper to be uploaded.